501 filings
Page 2 of 26
8-K
wuvhlb3 gkdn74mf506
6 May 20
Announcement relating to the outcome of the Court Sanction Hearing
7:17am
8-K
67thk194o
21 Apr 20
Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
4:16pm
8-K
dnjl6 l34eap012i
18 Mar 20
AbbVie and Allergan Sign Consent Decree Agreement with Federal Trade Commission Staff on Pending Transaction
12:00am
8-K
5pydxi 3nsgdf6
3 Mar 20
AbbVie and Allergan Receive Final European Approval to Close Pending Transaction
4:05pm
8-K
ev3odx
10 Feb 20
Allergan Reports Fourth Quarter and Full-Year 2019 Financial Results
7:25am
8-K
yzfaa3o3vlmor6 df
27 Jan 20
AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep
8:00am
8-K
bzp8eopsz1djyd2m2 43
5 Nov 19
Third Quarter 2019 Financial Results—Frequently Asked Questions
8:11am
8-K
w9xpn65uz6vjrqnc9b
5 Nov 19
Allergan Reports Third Quarter 2019 Financial Results
7:17am
8-K
1atot44
15 Oct 19
Allergan Shareholders Approve Proposed Acquisition by AbbVie
6:30am
DEFA14A
x9k2j
3 Oct 19
Additional proxy soliciting materials
4:10pm
DEFA14A
2lnq7jlowrd9y oi49
27 Sep 19
Additional proxy soliciting materials
4:50pm
8-K
bceky4xgim6 7ets
27 Sep 19
Other Events
4:45pm
8-K
jx86to qvph4lgdm6l
16 Sep 19
Report of Pricewaterhousecoopers Ireland on Allergan Profit
4:16pm
DEFA14A
mweyi5
11 Sep 19
Additional proxy soliciting materials
12:00am
8-K
fglnimnlie so5ya8z
11 Sep 19
Other Events
12:00am